Cited by 239Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss

Open access
Paolicelli, Rosa C., Jawaid, Ali, Henstridge, Christopher M., Valeri, Andrea, Merlini, Mario, Robinson, John L., Lee, Edward B., Rose, Jamie +6 more·2017·Neuron

Abstract

Microglia coordinate various functions in the central nervous system ranging from removing synaptic connections, to maintaining brain homeostasis by monitoring neuronal function, and clearing protein aggregates across the lifespan. Here we investigated whether increased microglial phagocytic activity that clears amyloid can also cause pathological synapse loss. We identified TDP-43, a DNA-RNA binding protein encoded by the Tardbp gene, as a strong regulator of microglial phagocytosis. Mice lacking TDP-43 in microglia exhibit reduced amyloid load in a model of Alzheimer's disease (AD) but at the same time display drastic synapse loss, even in the absence of amyloid. Clinical examination from TDP-43 pathology cases reveal a considerably reduced prevalence of AD and decreased amyloid pathology compared to age-matched healthy controls, confirming our experimental results. Overall, our data suggest that dysfunctional microglia might play a causative role in the pathogenesis of neurodegenerative disorders, critically modulating the early stages of cognitive decline.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2017.05.037

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tardbp is protective against synapse loss in an Alzheimer's disease mouse model, whereas its absence promotes higher amyloid clearance by enhancing phagocytosis.

    “Tardbp has been shown recently to be protective against synapse loss in an AD mouse model, whereas its absence promotes higher amyloid clearance by enhancing phagocytosis”

    From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Paolicelli et al., 2017

  • Quantification of internalized PSD95 in individual microglia in the dentate gyrus showed an increase in steady-state internal PSD95 in XO4− microglia compared to XO4+ microglia (p = 0.0057).

    “Quantification of the internalized post-synaptic marker, PSD9546, in individual microglia in the dentate gyrus of WT and 5xFAD mice (Fig. 4a and Supplementary Fig. 10a) showed an increase in steady-state internal PSD95 in XO4− microglia compared to XO4+ microglia (Fig. 4b; p = 0.0057, one-way ANOVA and Tukey’s multiple comparison test).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Arnold S.E. Toledo J.B. Appleby D.H. Xie S.X. Wang L.S. Baek Y. Wolk D.A. Lee E.B. Miller B.L. Lee V.M. Trojanowski J.Q. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases J. Comp. Neurol. 521 2013 4339 4355 23881776 PMC3872132
  2. Bali J. Gheinani A.H. Zurbriggen S. Rajendran L. Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptides Proc. Natl. Acad. Sci. USA 109 2012 15307 15311 22949636 PMC3458335
  3. Baralle M. Buratti E. Baralle F.E. The role of TDP-43 in the pathogenesis of ALS and FTLD Biochem. Soc. Trans. 41 2013 1536 1540 24256250
  4. Boluda S. Toledo J.B. Irwin D.J. Raible K.M. Byrne M.D. Lee E.B. Lee V.M. Trojanowski J.Q. A comparison of Aβ amyloid pathology staging systems and correlation with clinical diagnosis Acta Neuropathol. 128 2014 543 550 24916271 PMC4399383
  5. Braak H. Braak E. Evolution of neuronal changes in the course of Alzheimer’s disease J. Neural Transm. Suppl. 53 1998 127 140 9700651
  6. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors J. Neurol. Sci. 124 Suppl 1994 96 107 7807156
  7. Buratti E. Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9 J. Biol. Chem. 276 2001 36337 36343 11470789
  8. Buratti E. Baralle F.E. The molecular links between TDP-43 dysfunction and neurodegeneration Adv. Genet. 66 2009 1 34 19737636
  9. Chiang P.M. Ling J. Jeong Y.H. Price D.L. Aja S.M. Wong P.C. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism Proc. Natl. Acad. Sci. USA 107 2010 16320 16324 20660762 PMC2941284
  10. Cohen T.J. Lee V.M. Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies Trends Mol. Med. 17 2011 659 667 21783422 PMC3202652
  11. Cole G.M. Bell L. Truong Q.B. Saitoh T. An endosomal-lysosomal pathway for degradation of amyloid precursor protein Ann. N Y Acad. Sci. 674 1992 103 117 1288357
  12. Cook C. Zhang Y.J. Xu Y.F. Dickson D.W. Petrucelli L. TDP-43 in neurodegenerative disorders Expert Opin. Biol. Ther. 8 2008 969 978 18549326 PMC2855963
  13. Deierborg T. Preparation of primary microglia cultures from postnatal mouse and rat brains Methods Mol. Biol. 1041 2013 25 31 23813366
  14. Derecki N.C. Katzmarski N. Kipnis J. Meyer-Luehmann M. Microglia as a critical player in both developmental and late-life CNS pathologies Acta Neuropathol. 128 2014 333 345 25056803 PMC4131160
  15. Diaper D.C. Adachi Y. Sutcliffe B. Humphrey D.M. Elliott C.J. Stepto A. Ludlow Z.N. Vanden Broeck L. Callaerts P. Dermaut B. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes Hum. Mol. Genet. 22 2013 1539 1557 23307927 PMC3605831
  16. Fa M. Orozco I.J. Francis Y.I. Saeed F. Gong Y. Arancio O. Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices J. Vis. Exp. 41 2010 1884 20644518 PMC3156071
  17. Feng G. Mellor R.H. Bernstein M. Keller-Peck C. Nguyen Q.T. Wallace M. Nerbonne J.M. Lichtman J.W. Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP Neuron 28 2000 41 51 11086982
  18. Gendron T.F. Petrucelli L. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration J. Mol. Neurosci. 45 2011 486 499 21811811 PMC3207125
  19. Goldmann T. Wieghofer P. Jordão M.J. Prutek F. Hagemeyer N. Frenzel K. Amann L. Staszewski O. Kierdorf K. Krueger M. Origin, fate and dynamics of macrophages at central nervous system interfaces Nat. Immunol. 17 2016 797 805 27135602 PMC4968048
  20. Handley E.E. Pitman K.A. Dawkins E. Young K.M. Clark R.M. Jiang T.C. Turner B.J. Dickson T.C. Blizzard C.A. Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies Cereb Cortex. 2016 Published online August 5, 2016 27496536
  21. Igaz L.M. Kwong L.K. Lee E.B. Chen-Plotkin A. Swanson E. Unger T. Malunda J. Xu Y. Winton M.J. Trojanowski J.Q. Lee V.M. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice J. Clin. Invest. 121 2011 726 738 21206091 PMC3026736
  22. Iguchi Y. Katsuno M. Niwa J. Takagi S. Ishigaki S. Ikenaka K. Kawai K. Watanabe H. Yamanaka K. Takahashi R. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration Brain 136 2013 1371 1382 23449777
  23. Jawaid A. Murthy S.B. Wilson A.M. Qureshi S.U. Amro M.J. Wheaton M. Simpson E. Harati Y. Strutt A.M. York M.K. Schulz P.E. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS Amyotroph. Lateral Scler. 11 2010 542 548 20500116
  24. Keage H.A. Hunter S. Matthews F.E. Ince P.G. Hodges J. Hokkanen S.R. Highley J.R. Dening T. Brayne C. TDP-43 pathology in the population: prevalence and associations with dementia and age J. Alzheimers Dis. 42 2014 641 650 25170584
  25. LaClair K.D. Donde A. Ling J.P. Jeong Y.H. Chhabra R. Martin L.J. Wong P.C. Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model Acta Neuropathol. 132 2016 859 873 27785573 PMC5131701
  26. Lagier-Tourenne C. Polymenidou M. Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration Hum. Mol. Genet. 19 R1 2010 R46 R64 20400460 PMC3167692
  27. Lee E.B. Leng L.Z. Zhang B. Kwong L. Trojanowski J.Q. Abel T. Lee V.M. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice J. Biol. Chem. 281 2006 4292 4299 16361260
  28. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan E.M. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease Neurology 34 1984 939 944 6610841
  29. Medina D.X. Orr M.E. Oddo S. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice Neurobiol. Aging 35 2014 79 87 23954172
  30. Nakanishi H. Microglial functions and proteases Mol. Neurobiol. 27 2003 163 176 12777686
  31. Neary D. Snowden J.S. Gustafson L. Passant U. Stuss D. Black S. Freedman M. Kertesz A. Robert P.H. Albert M. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554 9855500
  32. Neumann M. Sampathu D.M. Kwong L.K. Truax A.C. Micsenyi M.C. Chou T.T. Bruce J. Schuck T. Grossman M. Clark C.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133 17023659
  33. Neumann M. Kwong L.K. Lee E.B. Kremmer E. Flatley A. Xu Y. Forman M.S. Troost D. Kretzschmar H.A. Trojanowski J.Q. Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies Acta Neuropathol. 117 2009 137 149 19125255 PMC2693625
  34. Ossenkoppele R. Jansen W.J. Rabinovici G.D. Knol D.L. van der Flier W.M. van Berckel B.N. Scheltens P. Visser P.J. Verfaillie S.C. Zwan M.D. Amyloid PET Study Group Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis JAMA 313 2015 1939 1949 25988463 PMC4517678
  35. Paolicelli R.C. Gross C.T. Microglia in development: linking brain wiring to brain environment Neuron Glia Biol. 7 2011 77 83 22857738
  36. Paresce D.M. Ghosh R.N. Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor Neuron 17 1996 553 565 8816718
  37. Parkhurst C.N. Yang G. Ninan I. Savas J.N. Yates J.R. 3rd Lafaille J.J. Hempstead B.L. Littman D.R. Gan W.B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor Cell 155 2013 1596 1609 24360280 PMC4033691
  38. Romano G. Appocher C. Scorzeto M. Klima R. Baralle F.E. Megighian A. Feiguin F. Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms Hum. Mol. Genet. 24 2015 6134 6145 26276811 PMC4599672
  39. Terry R.D. Masliah E. Salmon D.P. Butters N. DeTeresa R. Hill R. Hansen L.A. Katzman R. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580 1789684
  40. Toledo J.B. Van Deerlin V.M. Lee E.B. Suh E. Baek Y. Robinson J.L. Xie S.X. McBride J. Wood E.M. Schuck T. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank Alzheimers Dement. 10 2014 477 484 23978324 PMC3933464
  41. Tremblay M.E. Stevens B. Sierra A. Wake H. Bessis A. Nimmerjahn A. The role of microglia in the healthy brain J. Neurosci. 31 2011 16064 16069 22072657 PMC6633221
  42. Vanden Broeck L. Naval-Sánchez M. Adachi Y. Diaper D. Dourlen P. Chapuis J. Kleinberger G. Gistelinck M. Van Broeckhoven C. Lambert J.C. TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila Cell Rep. 3 2013 160 172 23333275
  43. Vekrellis K. Ye Z. Qiu W.Q. Walsh D. Hartley D. Chesneau V. Rosner M.R. Selkoe D.J. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J. Neurosci. 20 2000 1657 1665 10684867 PMC6772918
  44. Wakselman S. Béchade C. Roumier A. Bernard D. Triller A. Bessis A. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor J. Neurosci. 28 2008 8138 8143 18685038 PMC6670768
  45. Walker A.K. Tripathy K. Restrepo C.R. Ge G. Xu Y. Kwong L.K. Trojanowski J.Q. Lee V.M. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice Hum. Mol. Genet. 24 2015 7241 7254 26476406 PMC5007600
  46. Wu L.S. Cheng W.C. Shen C.K. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice J. Biol. Chem. 287 2012 27335 27344 22718760 PMC3431639
  47. Xu Y.F. Zhang Y.J. Lin W.L. Cao X. Stetler C. Dickson D.W. Lewis J. Petrucelli L. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice Mol. Neurodegener. 6 2011 73 22029574 PMC3216869
  48. Yang C. Wang H. Qiao T. Yang B. Aliaga L. Qiu L. Tan W. Salameh J. McKenna-Yasek D.M. Smith T. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. USA 111 2014 E1121 E1129 24616503 PMC3970502
  49. Ying Z. Xia Q. Hao Z. Xu D. Wang M. Wang H. Wang G. TARDBP/TDP-43 regulates autophagy in both MTORC1-dependent and MTORC1-independent manners Autophagy 12 2016 707 708 27050460 PMC4836031

Cited by

Sorted by citations

Authors
Paolicelli, R. C., Jawaid, A., Henstridge, C. M., Valeri, A., Merlini, M., Robinson, J. L., Lee, E. B., Rose, J., Appel, S., Lee, V. M.-Y., Trojanowski, J. Q., Spires-Jones, T., Schulz, P. E., & Rajendran, L.
Affiliations
  • University of Zurich (CH)
  • University of Edinburgh (GB)
  • University of Pennsylvania (US)
  • Houston Methodist (US)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
  • Paolicelli, Rosa C.
  • Rajendran, Lawrence
Venue
Neuron
Publisher
Elsevier BV
Published
2017-07
Volume
95
Issue
2
Pages
297-308.e6
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2732599352
Cited by
239
References
20
Citations by year
2026: 18 · 2025: 17 · 2024: 37 · 2023: 21 · 2022: 32 · 2021: 29 · 2020: 30 · 2019: 21 · 2018: 25 · 2017: 8
FWCI
11.44
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc-nd)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • ETH Zürich Research Collection
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Swiss National Science Foundation (SNF)
  • Synapsis Foundation Alzheimer Research Switzerland ARS
  • Velux Stiftung
  • Cure Alzheimer Fund
  • Sinergia
  • Interdisciplinary Core
  • Forschungskredit University of Zurich
  • Alzheimer’s Research UK, European Research Council
  • MND Scotland
  • Motor Neurone Disease Scotland
  • European Research Council (ALZSYN)
  • Alzheimer’s Research UK
  • Scottish Government Chief Scientist Office
  • Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund
  • Alzheimer's Society
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
TDP-43, microglia, microglial phagocytosis, amyloid clearance, synaptic loss, Alzheimer's disease, TARDBP, neurodegeneration, cognitive decline, protein aggregate clearance
MeSH terms
Amyloid, Amyotrophic Lateral Sclerosis, Animals, Brain, Cognition, DNA-Binding Proteins, Mice, Transgenic, Synapses, Microglia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review